See also this year's filing and all EDGAR filings for this company.
PDF Report 0000931059_2016_Rennova_Health_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 4.679831657095631e-08, 'aggregate_val': 21368289, 'exp_sum': 21368290, 'exp_to_value': {'LongTermLiabilities': 0, 'LiabilitiesCurrent': 19564768, 'remainder_Liabilities': 1803522}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000931059, Rennova Health Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 0 |
| 2 | AssetsCurrent | 20,590,804 |
| 3 | PropertyPlantAndEquipment | 7,148,295 |
| 4 | remainder_Assets | 232,774 |
| 5 | LongTermLiabilities | 2,903,898 |
| 6 | LiabilitiesCurrent | 16,372,117 |
| 7 | remainder_Liabilities | 9,889,657 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 9,339,644 |
| 10 | GeneralAndAdministrativeExpense | 27,846,160 |
| 11 | GoodwillImpairmentLoss | 18,411,353 |
| 12 | OperatingCostsAndExpenses | 415,482 |
| 13 | DepreciationDepletionAndAmortization | 2,749,850 |
| 14 | SellingAndMarketingExpense | 3,763,802 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | -8,928,499 |
| 17 | remainder_Revenues | 0 |
| 18 | remainder_NetIncome | 18,867,253 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 27,971,873 |
| 1 | Liabilities | 29,165,672 |
| 2 | Expenses | 53,597,792 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -1,193,799 |
| 5 | NetIncome | -34,730,539 |
| 6 | ComprehensiveNetIncome | -34,730,539 |
| 7 | BaseVar | 64,801,295 |
| 8 | EconomicCapitalRatio | -1.33 |
Edgar->Model Mapping
Feature Distribution
Change over Time
